Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > COMMENTARY
COMMENTARY
-
Competition Fuels Personalized Medicine Market, First-Line Positions Eyed for Xalkori, Alecensa
July 28, 2014
-
Can New Fast-Track Review System Perk Up Drug Makers’ Development Drive in Japan?
July 7, 2014
-
June Reimbursement Listing Could Mark Watershed in Japan Generic Market
July 1, 2014
-
Two Reasons MHLW Opposes Yearly NHI Price Revisions, “Annual” Dropped from Gov’t Policy Guidelines
June 17, 2014
-
Delicate Balancing Act Required for SGLT-2 Inhibitor Promotions - Safety vs Efficacy
June 16, 2014
-
Why Not Make RMPs for Existing Products as Differentiation Strategy?
June 9, 2014
-
2013 Earnings Signal Foreign Drug Makers Losing Steam in Japan
June 2, 2014
-
Clinical Research Regulations at Crossroads: Guidelines or Legislation?
May 26, 2014
-
Was the Main Paper from VART Study “Practice” for a Grad Student?
May 19, 2014
-
Can CROs Become Independent Players? Compliance, Ethics Will Be Major Issues for Growing Industry
April 28, 2014
-
Industry Faces Tough Road to Institutionalization of Key Premium, Eligibility Up for Discussion
April 21, 2014
-
Approval of Novel Antiepileptic Drugs as Monotherapies Coming Closer to Reality
April 7, 2014
-
Will Japan NIH Initiative Create a “Japanese Model” that Overcomes Its Size Disadvantage?
March 28, 2014
-
CASE-J Flutter: Doesn’t Blopress Ad Overemphasize Its Benefits on Diabetes?
March 19, 2014
-
“Lack of Urgency” Leads to New Rule; Penalty for Low Price Settlement Rates May Have Been Inevitable
March 12, 2014
-
Hardships and Successes of Diversified Entrants Lead to Question: Will Pharmaceuticals Continue to Be a Growth Sector?
March 5, 2014
-
Revised JCS Guidelines Clarify Role of Novel Oral Anticoagulants in Patients with Atrial Fibrillation
February 12, 2014
-
Will JPWA’s Move to Integrate Tax Display Method Dispel Medical Institutions’ Misconception?
January 31, 2014
-
FY2014 May Be Year 1 of New Reform Era; Drug Makers Need to “Turn Calamity into Good Fortune”
January 7, 2014
-
First SGLT-2 Inhibitor Set to Debut Next April; Curtain Rising on “Unprecedentedly Competitive” Market
December 18, 2013
